Tianfeng Securities Co., Ltd. (601162.SS) Bundle
Who is buying Tianfeng Securities Co., Ltd. (601162.SS) and why it matters: retail investors dominate with 59% of shares, private companies hold 27%, institutions about 12%, while the largest individual shareholder, Wuhan Tianfeng Investment, controls 26.27% and Hubei Tianfeng Investment owns 6.12%; among institutional players Hubei Hongtai Group leads with 13.09% (Sept 30, 2024) and Wuhan Industrial Investment holds 7.55%, supported by stakes from Wuhan Financial Holding (1.94%), Humanwell Healthcare (1.31%), China Southern Asset Management (1.29%) and Guotai Asset Management (1.25%); market metrics as of Dec 12, 2025 show a stock price of CNY 4.23, a market cap of CNY 42.61 billion, a 16.57% one‑year decline, trailing P/E of 65.96, forward P/E of 1,063.27 and a beta of 0.96 - read on to unpack who's shaping strategy, governance and market sentiment at Tianfeng.
Tianfeng Securities Co., Ltd. (601162.SS) - Who Invests in Tianfeng Securities Co., Ltd. and Why?
Tianfeng Securities displays a diversified ownership structure dominated by retail (individual) investors, significant private/corporate stakes, and a smaller institutional presence. The mix signals public confidence, corporate strategic interest, and selective professional allocation to the stockbrokerage/financial services franchise.- Individual investors: 59% - strong retail participation and confidence in the company's business model and growth prospects.
- Private companies (non-institutional corporates): 27% - substantial corporate holdings that may reflect strategic or financial investments.
- Institutional investors: ~12% - moderate professional ownership, indicating institutional selectivity or regulatory/sector constraints.
| Ownership Category | Stake (%) | Implication |
|---|---|---|
| Individual investors | 59% | High retail liquidity and voting fragmentation; sensitivity to public sentiment |
| Private/corporate investors | 27% | Corporate influence and potential strategic coordination |
| Institutional investors | 12% | Moderate professional endorsement; room to increase if fundamentals improve |
- Wuhan Tianfeng Investment Co., Ltd. - 26.27% (largest single shareholder; major influence on governance and strategic direction)
- Hubei Tianfeng Investment Co., Ltd. - 6.12% (significant corporate stake reinforcing regional/affiliate support)
- Retail appeal: accessible equity story and perceived upside in brokerage/wealth management revenue growth.
- Corporate alignment: private company stakes suggest strategic or financial synergy expectations.
- Institutional allocation: selective exposure by funds seeking diversified China financials with franchise value.
Institutional Ownership and Major Shareholders of Tianfeng Securities Co., Ltd. (601162.SS)
As of September 30, 2024, institutional investors play a meaningful role in the shareholder base of Tianfeng Securities Co., Ltd. (601162.SS). The six largest institutional holders listed below together own 26.43% of outstanding shares, signaling concentrated institutional interest from both state-related and asset-management organizations.
- Hubei Hongtai Group Co., Ltd. - 13.09%
- Wuhan Industrial Investment Holding Group Co., Ltd. - 7.55%
- Wuhan Financial Holding (Group) Co., Ltd. - 1.94%
- Humanwell Healthcare (Group) Co., Ltd. - 1.31%
- China Southern Asset Management Co., Ltd. - 1.29%
- Guotai Asset Management Company Limited - 1.25%
| Shareholder | Type | Holding (%) | Notes (as of 2024-09-30) |
|---|---|---|---|
| Hubei Hongtai Group Co., Ltd. | State/Regional Group | 13.09 | Largest single institutional stake - strategic influence potential |
| Wuhan Industrial Investment Holding Group Co., Ltd. | State/Investment Holding | 7.55 | Significant regional investor exposure to financial sector |
| Wuhan Financial Holding (Group) Co., Ltd. | State Financial Holding | 1.94 | Complementary to other Wuhan-based institutional stakes |
| Humanwell Healthcare (Group) Co., Ltd. | Corporate Investor | 1.31 | Cross-industry corporate investor, diversifying holder mix |
| China Southern Asset Management Co., Ltd. | Asset Manager | 1.29 | Professional asset manager - tradable/investment mandate |
| Guotai Asset Management Company Limited | Asset Manager | 1.25 | Institutional diversification via mutual/fund holdings |
- Total stake held by the six named institutions: 26.43%
- Dominant regional/state influence via Hubei Hongtai and Wuhan groups
- Professional asset managers (China Southern, Guotai) together: 2.54%
- Presence of a non-financial corporate investor (Humanwell) indicates cross-sector interest
For deeper financial context and operating metrics that investors referenced when taking these positions, see: Breaking Down Tianfeng Securities Co., Ltd. Financial Health: Key Insights for Investors
Tianfeng Securities Co., Ltd. (601162.SS) Key Investors and Their Impact on Tianfeng Securities Co., Ltd.
Tianfeng Securities' shareholder base is a mix of major strategic local owners and diversified institutional investors. Their stakes shape governance, strategic priorities, risk tolerance and capital access. Below is a focused breakdown of the principal investors, their holdings and the likely impact of their ownership on company direction and operations.- Hubei Hongtai Group Co., Ltd. - 13.09%: Largest single shareholder with potential to influence board composition, major strategic decisions, regional business ties and long-term capital allocation.
- Wuhan Industrial Investment Holding Group Co., Ltd. - 7.55%: Significant state-affiliated holder likely to affect corporate governance standards, infrastructure financing links and alignment with municipal economic priorities.
- Wuhan Financial Holding (Group) Co., Ltd. - 1.94%: Institutional financial investor that supports balance-sheet stability and can facilitate financial partnerships or intergroup cooperation.
- Humanwell Healthcare (Group) Co., Ltd. - 1.31%: Corporate investor from healthcare brings sector diversification to the shareholder base and potential cross-industry collaboration opportunities.
- China Southern Asset Management Co., Ltd. - 1.29%: Asset manager representing professional institutional confidence; typically supports growth initiatives while seeking risk-adjusted returns.
- Guotai Asset Management Company Limited - 1.25%: Another asset manager whose stake signals market endorsement of Tianfeng Securities' earnings potential and governance.
| Investor | Stake | Investor Type | Likely Strategic Impact |
|---|---|---|---|
| Hubei Hongtai Group Co., Ltd. | 13.09% | State/Corporate Strategic Shareholder | Control influence on board, regional strategy alignment, priority access to local projects |
| Wuhan Industrial Investment Holding Group Co., Ltd. | 7.55% | State Investment Vehicle | Governance oversight, facilitation of municipal financing and industrial partnerships |
| Wuhan Financial Holding (Group) Co., Ltd. | 1.94% | Financial Holding / Institutional | Support for financial stability, potential for inter-group capital/information flows |
| Humanwell Healthcare (Group) Co., Ltd. | 1.31% | Corporate Investor (Healthcare) | Sector diversification of shareholder base, possible cross-sector collaboration |
| China Southern Asset Management Co., Ltd. | 1.29% | Asset Manager | Professional institutional backing, focus on performance and governance |
| Guotai Asset Management Company Limited | 1.25% | Asset Manager | Confidence signal to markets, support for capital markets operations |
- Ownership concentration: The top two shareholders (Hubei Hongtai and Wuhan Industrial Investment) collectively hold 20.64%, indicating substantial local/state influence on strategic direction.
- Institutional layer: Asset managers and financial holding entities together provide liquidity, market credibility and an investor base that expects disciplined financial performance.
- Cross-sector influence: Presence of a healthcare corporate investor and multiple municipal/state groups expands potential strategic partnerships beyond pure brokerage activities.
Tianfeng Securities Co., Ltd. (601162.SS) - Market Impact and Investor Sentiment
Tianfeng Securities' market snapshot as of December 12, 2025 signals a mixed investor narrative: a materially sized market-cap presence but recent price pressure and lofty valuation multiples that suggest differentiated expectations between current fundamentals and forward hopes.| Metric | Value |
|---|---|
| Share Price | CNY 4.23 |
| Market Capitalization | CNY 42.61 billion |
| 1‑Year Price Change | -16.57% |
| Trailing P/E | 65.96 |
| Forward P/E | 1,063.27 |
| Beta (3Y) | 0.96 |
- Immediate market impression: a mid‑cap brokerage with substantial market presence (CNY 42.61B) but an underperforming stock over the past 12 months (-16.57%), which typically cools retail sentiment and triggers scrutiny from value‑oriented investors.
- Valuation tension: trailing P/E at 65.96 reflects investors paying a premium for reported earnings, while an extremely high forward P/E (1,063.27) signals either an expectation of negligible near‑term earnings or outsized anticipated growth/one‑off items in future earnings forecasts.
- Volatility and risk perception: beta ~0.96 suggests share volatility is roughly in line with the market, moderating risk premiums for institutional holders who focus on systematic risk rather than idiosyncratic swings.
- Who's likely buying now:
- Growth/turnaround oriented funds that accept stretched forward multiples betting on trajectory improvements or earnings rebounds.
- Quantitative and momentum traders attracted by relative stability (beta ~1) once short‑term downside consolidates.
- Long‑term strategic holders or local institutional investors valuing market share and franchise value in China's securities sector.
- Who might be selling:
- Value funds discouraged by a 16.57% one‑year decline and high trailing P/E on current earnings.
- Event‑driven or volatility‑sensitive traders reacting to earnings uncertainty implied by the forward P/E spike.
- Sentiment drivers to watch:
- Earnings revisions - upgrades would justify rich multiples; downgrades would magnify downside.
- Regulatory or market‑structure changes in China's securities industry that affect brokerage margins and non‑interest income.
- Capital flows: shifts in institutional allocation to domestic financials versus offshore alternatives.
For context on the firm's strategic framing and long‑term priorities that inform investor expectations, see: Mission Statement, Vision, & Core Values (2026) of Tianfeng Securities Co., Ltd.
Tianfeng Securities Co., Ltd. (601162.SS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.